PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
2.23%
Revenue growth under 50% of AR's 23.04%. Michael Burry would suspect a deteriorating sales pipeline or weaker brand.
-2.71%
Negative gross profit growth while AR is at 24.02%. Joel Greenblatt would examine cost competitiveness or demand decline.
-72.59%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-72.59%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-233.51%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-236.00%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-236.00%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-63.55%
Dividend reduction while AR stands at 0.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
-50.59%
Negative OCF growth while AR is at 45.31%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-186.73%
Negative FCF growth while AR is at 52.25%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
-3.08%
Negative 10Y revenue/share CAGR while AR stands at 152.24%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-78.20%
Negative 5Y CAGR while AR stands at 152.24%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-0.83%
Negative 3Y CAGR while AR stands at 152.24%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
8.61%
10Y OCF/share CAGR under 50% of AR's 88.35%. Michael Burry would worry about a persistent underperformance in cash creation.
-77.02%
Negative 5Y OCF/share CAGR while AR is at 88.35%. Joel Greenblatt would question the firm’s operational model or cost structure.
-49.86%
Negative 3Y OCF/share CAGR while AR stands at 88.35%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
-222.60%
Both face negative decade-long net income/share CAGR. Martin Whitman would suspect a shrinking or highly disrupted sector.
-123.68%
Both exhibit negative net income/share growth over five years. Martin Whitman would suspect a challenging environment for the entire niche.
-496.00%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
-21.02%
Negative equity/share CAGR over 10 years while AR stands at 113.41%. Joel Greenblatt sees a fundamental red flag unless the competitor also struggles.
-77.23%
Negative 5Y equity/share growth while AR is at 113.41%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
-70.38%
Negative 3Y equity/share growth while AR is at 113.41%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
637.70%
Dividend/share CAGR of 637.70% while AR is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
-86.79%
Negative 5Y dividend/share CAGR while AR stands at 0.00%. Joel Greenblatt sees a weaker commitment to dividends vs. a competitor that might be growing them.
-73.54%
Negative near-term dividend growth while AR invests at 0.00%. Joel Greenblatt sees a weaker short-term distribution policy unless justified by strategic spending.
114.38%
Our AR growth while AR is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
81.02%
We show growth while AR is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
-4.00%
Negative asset growth while AR invests at 16.60%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-4.91%
We have a declining book value while AR shows 90.21%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
-0.48%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
21.70%
SG&A declining or stable vs. AR's 2563.65%. David Dodd sees better overhead efficiency if it doesn't hamper revenue.